STOP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of STOP Antibodies for advanced research in cellular signaling and regulation. STOP Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The STOP protein, also known as the "Striatal-Enriched Protein Tyrosine Phosphatase," plays a critical role in neuronal signaling pathways and influences synaptic function and plasticity. STOP protein has been linked to neurodegenerative diseases and represents a promising therapeutic target. Research focused on STOP protein continues to reveal new insights into neurological disorders and their underlying mechanisms. Understanding STOP protein function advances knowledge of brain development, synaptic plasticity, and neuronal communication. Investigating STOP protein expression patterns helps identify potential therapeutic interventions for various neurological conditions. STOP monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance neuroscience research and contribute to developing new therapeutic strategies.